Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew B Lassman
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
285 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- John Muir Medical Center-Concord
Concord, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-Ontario
Ontario, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Torrance Memorial Medical Center
Torrance, California, United States
- Torrance Memorial Physician Network - Cancer Care
Torrance, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Adventhealth Littleton
Littleton, Colorado, United States
- Adventhealth Parker
Parker, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Beebe South Coastal Health Campus
Millville, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Delaware Clinical and Laboratory Physicians Pa
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Baptist Md Anderson Cancer Center
Jacksonville, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- Lewis Cancer and Research Pavilion at Saint Joseph'S/candler
Savannah, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Lewis Hall Singletary Oncology Center
Thomasville, Georgia, United States
- Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
- Hawaii Cancer Care Inc-Liliha
Honolulu, Hawaii, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2020
- Primary completion
- 13 Jan 2023
- Completion
- 23 Dec 2025
- Last update posted
- 22 Apr 2026
- Registered enrollment
- 159
- Registry id
- NCT04396860
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.